 |
|
Probenecid-Induced Norepinephrine Elevations in Plasma and CSF
C. Raymond Lake, MD, PhD;
James H. Wood, MD;
Michael G. Ziegler, MD;
Michael H. Ebert, MD;
Irwin J. Kopin, MD
Arch Gen Psychiatry. 1978;35(2):237-240.
Abstract
• Probenecid administered in divided oral doses totaling 100 mg/kg increased levels of norepinephrine (NE) in plasma and cerebrospinal fluid (CSF). This technique is commonly used to measure the rate of accumulation of acidic metabolites of certain brain neurotransmitter biogenic amines in CSF after blockade of their transport into blood. Since levels of 3-methoxy-4-hydroxyphenylethyleneglycol, a neutral metabolite of NE, are also elevated after high oral doses of probenecid, the increases of CSF and plasma NE levels may be directly related to probenecidinduced release of this amine from noradrenergic neurons.
In patients who experienced nausea or vomiting there were lower levels of probenecid in CSF, probably secondary to diminished absorption of the medication. These patients also had lower levels of NE in plasma than did patients who remained asymptomatic.
Author Affiliations
From the Laboratory of Clinical Science, National Institute of Mental Health (Drs Lake, Ziegler, Ebert, and Kopin), and the Surgical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke (Dr Wood), Bethesda, Md.
Footnotes
Accepted for publication Oct 20, 1976.
Reprint requests to Laboratory of Clinical Science, National Institute of Mental Health, Bldg 10, Room 2D-46, Bethesda, MD 20014 (Dr Lake).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cerebrospinal Fluid Monoamine Metabolites, Aggression, and Impulsivity in Disruptive Behavior Disorders of Children and Adolescents
Kruesi et al.
Arch Gen Psychiatry 1990;47:419-426.
ABSTRACT
|
